Overview

Fenofibrate Bioequivalence Study (0767-031)

Status:
Completed

Trial end date:
2004-04-01

Target enrollment:

Participant gender:

Summary

This study will determine definitive bioequivalence of the United States (U.S.) and United Kingdom (UK) formulations of fenofibrate following administration of single doses in healthy adult subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Fenofibrate